Glenmark Pharmaceuticals Limited — Others, 12-05-2025: Trading Window

Glenmark Pharmaceuticals Limited has announced a board meeting to approve the financial results for the quarter and year ended March 31, 2025, and to discuss a potential dividend on equity shares. The trading window will remain closed until after the meeting, ensuring compliance with insider trading policies. This update is key for shareholders monitoring the company’s financial performance and dividend prospects.